The Korean Journal of Clinical Oncology (Korean J Clin Oncol, KJCO) is an official publication of the Korean Society of Surgical Oncology. KJCO serves its readers as the single most credible, authoritative resource for disseminating significant clinical oncology research. This journal aims to extend the lifespan and improve the quality of life for cancer patients through comprehensive research, not only focused on cancer treatment but also covering a broad range of cancer-related studies. Its scope includes a wide range of tumors, such as gastrointestinal, breast, head and neck cancers, soft tissue tumors, and tumors of other organs.

To this end, KJCO welcomes submissions across a broad spectrum of topics within clinical oncology, including but not limited to:

• Cancer genetics and genomics
• Cancer metabolism and molecular oncology
• Cellular and immuno-oncology
• Epidemiology and cancer prevention
• Surgical oncology
• Radiotherapy and chemotherapy
• Palliative care and survivorship: supportive care and quality of life issues
• Precision medicine
• Clinical trials and novel therapeutic approaches
• Artificial Intelligence and Machine Learning in Oncology

The journal publishes original articles, reviews, case reports, correspondences, editorials. The journal is published three times a year, in April, August, and December, and is distributed to members of the Korean Society of Surgical Oncology, medical schools, libraries, and related institutes to advance academic knowledge in clinical oncology and promote active communication between members and international societies of clinical oncology.

We invite researchers and clinicians to submit their latest findings and perspectives, contributing to a vibrant, interdisciplinary dialogue that will shape the future of clinical oncology.